business
Compass Pathways jumps after earnings beat and accelerated FDA review progress (CMPS)
Compass Pathways jumps after earnings beat and accelerated FDA review progress (CMPS)
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
Widepoint C earnings beat by $0.07, revenue topped estimates
Investing.com
Globant SA earnings beat by $0.01, revenue topped estimates
Investing.com
RideNow earnings beat by $0.03, revenue topped estimates
Investing.com
Brookfield earnings beat by $0.03, revenue was in line with estimates
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop